Ligand validation:3WMV

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 3WMV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WMV_A2G_A_201	96%	9%	0.068	0.979	3.57	0.98	2	1	0	0	100%	1
3WMV_A2G_A_203	89%	15%	0.089	0.967	1.35	2.36	4	4	0	0	100%	1
3WMV_A2G_B_203	87%	36%	0.092	0.963	1.13	1.38	1	2	0	0	100%	1
3WMV_A2G_B_202	87%	45%	0.099	0.97	1	1.11	-	2	0	0	100%	1
3WMV_A2G_B_201	83%	26%	0.108	0.967	1.31	1.69	1	2	0	0	100%	1
3WMV_A2G_A_202	83%	43%	0.1	0.958	0.97	1.25	1	1	0	0	100%	1
8VCO_A2G_B_201	91%	41%	0.078	0.965	0.49	1.75	-	3	0	0	100%	1
5T5P_A2G_b_201	100%	25%	0.036	0.982	1.15	1.89	2	3	0	0	100%	0.9333
2CCV_A2G_A_1101	100%	23%	0.037	0.978	1.67	1.48	3	4	0	0	100%	1
2A2D_A2G_A_459	99%	12%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5L_A2G_b_201	99%	57%	0.047	0.984	0.74	0.89	-	1	0	0	100%	0.9333
5T5J_A2G_a_201	99%	42%	0.049	0.983	0.94	1.31	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.